Literature DB >> 19386031

Fatty acids and cardiovascular disease.

Jean-Michel Lecerf1.   

Abstract

Fatty acids have been classified into "good" or "bad" groups according to their degree of unsaturation or whether they are "animal fat" or "vegetable fat". Today, it appears that the effects of fatty acids are complex and vary greatly according to the dose and the nature of the molecule. Monounsaturated fatty acids are still considered as having a "neutral" status, but any benefits may be related to the chemical environment of the source food or the associated overall food pattern. Controversy surrounds omega-6 polyunsaturated fatty acids, because even though they lower LDL cholesterol levels, excessive intakes do not appear to be correlated with cardiovascular benefit. The omega-3 fatty acids are known to exert cardiovascular protective effects. Dairy fat and its cardiovascular impact are being evaluated. This review examines the existing literature on the relationships between the different fatty acids and cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19386031     DOI: 10.1111/j.1753-4887.2009.00194.x

Source DB:  PubMed          Journal:  Nutr Rev        ISSN: 0029-6643            Impact factor:   7.110


  14 in total

1.  Genetic variation in fatty acid elongases is not associated with intermediate cardiovascular phenotypes or myocardial infarction.

Authors:  S Aslibekyan; M K Jensen; H Campos; C D Linkletter; E B Loucks; J M Ordovas; R Deka; E B Rimm; A Baylin
Journal:  Eur J Clin Nutr       Date:  2012-02-01       Impact factor: 4.016

Review 2.  Applications of mass spectrometry for cellular lipid analysis.

Authors:  Chunyan Wang; Miao Wang; Xianlin Han
Journal:  Mol Biosyst       Date:  2015-01-19

3.  Measurement of spices and seasonings in India: opportunities for cancer epidemiology and prevention.

Authors:  Leah M Ferrucci; Carrie R Daniel; Kavita Kapur; Puneet Chadha; Hemali Shetty; Barry I Graubard; Preethi S George; Whitney Osborne; Susan Yurgalevitch; Niveditha Devasenapathy; Nilanjan Chatterjee; Dorairaj Prabhakaran; Prakash C Gupta; Aleyamma Mathew; Rashmi Sinha
Journal:  Asian Pac J Cancer Prev       Date:  2010

4.  Dairy products and plasma cholesterol levels.

Authors:  Lena Ohlsson
Journal:  Food Nutr Res       Date:  2010-08-19       Impact factor: 3.894

Review 5.  Genetic variation in lipid desaturases and its impact on the development of human disease.

Authors:  Diana M Merino; David W L Ma; David M Mutch
Journal:  Lipids Health Dis       Date:  2010-06-18       Impact factor: 3.876

6.  Decreased plasma cholesterol concentrations after PUFA-rich diets are not due to reduced cholesterol absorption/synthesis.

Authors:  Vanu R Ramprasath; Peter J H Jones; Donna D Buckley; Laura A Woollett; James E Heubi
Journal:  Lipids       Date:  2012-09-11       Impact factor: 1.880

Review 7.  Nutritional lipidomics: molecular metabolism, analytics, and diagnostics.

Authors:  Jennifer T Smilowitz; Angela M Zivkovic; Yu-Jui Yvonne Wan; Steve M Watkins; Malin L Nording; Bruce D Hammock; J Bruce German
Journal:  Mol Nutr Food Res       Date:  2013-07-01       Impact factor: 5.914

Review 8.  Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy.

Authors:  Qing Jiang
Journal:  Free Radic Biol Med       Date:  2014-04-03       Impact factor: 7.376

9.  Hepatic and plasma sex differences in saturated and monounsaturated fatty acids are associated with differences in expression of elongase 6, but not stearoyl-CoA desaturase in Sprague-Dawley rats.

Authors:  Kristin A Marks; Alex P Kitson; Ken D Stark
Journal:  Genes Nutr       Date:  2012-11-22       Impact factor: 5.523

10.  Avocado consumption is associated with better diet quality and nutrient intake, and lower metabolic syndrome risk in US adults: results from the National Health and Nutrition Examination Survey (NHANES) 2001-2008.

Authors:  Victor L Fulgoni; Mark Dreher; Adrienne J Davenport
Journal:  Nutr J       Date:  2013-01-02       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.